Drug Utilisation SubCommittee utilisation analysis public release documents

PBAC

18 March 2021 - The utilisation analysis public release documents from the October 2020 Drug Utilisation SubCommittee meeting are now available.

The Drug Utilisation SubCommittee considered:

  • Adrenaline
  • Alectinib hydrochloride
  • Denosumab
  • Eculizumab
  • Ibrutinib
  • Ocrelizumab

Read DUSC public release documents

Michael Wonder

Posted by:

Michael Wonder